Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study (vol 401, pg 269, 2023)

被引：0
|
作者：
Verstovsek, S.
Gerds, A. T.
Vannucchi, A. M.
机构：
来源：
LANCET | 2023年 / 401卷 / 10386期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1426 / 1426
页数：1
相关论文
共 50 条
  • [1] Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study (vol 401, pg 269, 2023)
    Allinson, James Peter
    Chaturvedi, Nishi
    Wong, Andrew
    LANCET, 2023, 402 (10418): : 2196 - 2196
  • [2] Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
    Verstovsek, Srdan
    Gerds, Aaron T.
    Vannucchi, Alessandro M.
    Al-Ali, Haifa Kathrin
    Lavie, David
    Kuykendall, Andrew T.
    Grosicki, Sebastian
    Iurlo, Alessandra
    Goh, Yeow Tee
    Lazaroiu, Mihaela C.
    Egyed, Miklos
    Fox, Maria Laura
    McLornan, Donal
    Perkins, Andrew
    Yoon, Sung -Soo
    Gupta, Vikas
    Kiladjian, Jean -Jacques
    Granacher, Nikki
    Lee, Sung-Eun
    Ocroteala, Luminita
    Passamonti, Francesco
    Harrison, Claire N.
    Klencke, Barbara J.
    Ro, Sunhee
    Donahue, Rafe
    Kawashima, Jun
    Mesa, Ruben
    LANCET, 2023, 401 (10373): : 269 - 280
  • [3] Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
    Gerds, Aaron T.
    Verstovsek, Srdan
    Vannucchi, Alessandro M.
    Al-Ali, Haifa Kathrin
    Lavie, David
    Kuykendall, Andrew
    Grosicki, Sebastian
    Iurlo, Alessandra
    Goh, Yeow Tee
    Lazaroiu, Mihaela C.
    Egyed, Miklos
    Fox, Maria Laura
    McLornan, Donal
    Perkins, Andrew
    Yoon, Sung-Soo
    Gupta, Vikas
    Kiladjian, Jean-Jacques
    Granacher, Nikki
    Lee, Sung-Eun
    Ocroteala, Luminita
    Passamonti, Francesco
    Harrison, Claire N.
    Oh, Stephen
    Klencke, Barbara J.
    Yu, Jing
    Donahue, Rafe
    Kawashima, Jun
    Mesa, Ruben
    LANCET HAEMATOLOGY, 2023, 10 (09): : E735 - E746
  • [4] Updated Results from the Momentum Phase 3 Study of Momelotinib (MMB) Versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor
    Gerds, Aaron T.
    Mesa, Ruben
    Vannucchi, Alessandro M.
    Al-Ali, Haifa Kathrin
    Lavie, David
    Kuykendall, Andrew
    Grosicki, Sebastian
    Iurlo, Alessandra
    Goh, Yeow Tee
    Lazaroiu, Mihaela
    Egyed, Miklos
    Fox, Maria Laura
    McLornan, Donal P.
    Perkins, Andrew Charles
    Yoon, Sung-Soo
    Gupta, Vikas
    Kiladjian, Jean-Jacques
    Donahue, Rafe
    Kawashima, Jun
    Verstovsek, Srdan
    BLOOD, 2022, 140 : 1514 - 1517
  • [5] Phase III randomized, double-blind, active-controlled study of momelotinib versus ruxolitinib in patients with myelofibrosis.
    Winton, Elliott F.
    Devos, Timothy
    Oh, Stephen T.
    Platzbecker, Uwe
    Wadleigh, Martha
    Jun, Susie
    Lee, Peter
    Deng, Wei
    Gupta, Vikas
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated With a JAK Inhibitor
    Mesa, Ruben
    Gerds, Aaron
    Vannucchi, Alessandro
    Al-Ali, Haifa Kathrin
    Lavie, David
    Kuykendall, Andrew
    Grosicki, Sebastian
    Iurlo, Alessandra
    Goh, Yeow Tee
    Lazaroiu, Mihaela
    Egyed, Miklos
    Fox, Maria Laura
    McLornan, Donal
    Perkins, Andrew
    Yoon, Sung-Soo
    Gupta, Vikas
    Kiladjian, Jean-Jacques
    Donahue, Rafe
    Kawashima, Jun
    Verstovsek, Srdan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S339 - S340
  • [7] The Impact of Momelotinib on Patient Reported Quality of Life for Symptomatic and Anemic Patients with Myelofibrosis: Results from the Phase 3 Momentum Study
    Mesa, Ruben
    Harrison, Claire
    Palmer, Jeanne M.
    Gupta, Vikas
    McLornan, Donal P.
    McMullin, Mary Frances
    Kiladjian, Jean-Jacques
    Foltz, Lynda
    Platzbecker, Uwe
    Fox, Maria Laura
    Mead, Adam J.
    Ross, David M.
    Oh, Stephen T.
    Perkins, Andrew Charles
    Leahy, Michael F.
    Kawashima, Jun
    Ro, Sunhee
    Donahue, Rafe
    Deheshi, Samineh
    Verstovsek, Srdan
    BLOOD, 2022, 140 : 9677 - 9680
  • [8] MOMENTUM: Phase 3 randomized study of momelotinib (MMB) versus danazol (DAN) in symptomatic and anemic myelofibrosis (MF) patients previously treated with a JAK inhibitor.
    Mesa, Ruben A.
    Gerds, Aaron Thomas
    Vannucchi, Alessandro
    Al-Ali, Haifa Kathrin
    Lavie, David
    Kuykendall, Andrew T.
    Grosicki, Sebastian
    Iurlo, Alessandra
    Goh, Yeow Tee
    Lazaroiu, Mihaela Cornelia
    Egyed, Miklos
    Fox, Maria Laura
    McLornan, Donal P.
    Perkins, Andrew
    Yoon, Sung-Soo
    Gupta, Vikas
    Kiladjian, Jean-Jacques
    Donahue, Rafe
    Kawashima, Jun
    Verstovsek, Srdan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Thrombocytopenic Myelofibrosis (MF) Patients Previously Treated With a JAK Inhibitor in a Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) [MOMENTUM]
    Gerds, Aaron
    Verstovsek, Srdan
    Vannucchi, Alessandro
    Al-Ali, Haifa Kathrin
    Lavie, David
    Kuykendall, Andrew
    Grosicki, Sebastian
    Iurlo, Alessandra
    Goh, Yeow Tee
    Lazaroiu, Mihaela
    Egyed, Miklos
    Fox, Maria Laura
    McLornan, Donal
    Perkins, Andrew
    Yoon, Sung-Soo
    Gupta, Vikas
    Kiladjian, Jean-Jacques
    Donahue, Rafe
    Kawashima, Jun
    Mesa, Ruben
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S340 - S340
  • [10] Thrombocytopenic myelofibrosis (MF) patients previously treated with a JAK inhibitor in a phase 3 randomized study of momelotinib (MMB) versus danazol (DAN) [MOMENTUM].
    Gerds, Aaron Thomas
    Verstovsek, Srdan
    Vannucchi, Alessandro
    Al-Ali, Haifa Kathrin
    Lavie, David
    Kuykendall, Andrew T.
    Grosicki, Sebastian
    Iurlo, Alessandra
    Goh, Yeow Tee
    Lazaroiu, Mihaela Cornelia
    Egyed, Miklos
    Fox, Maria Laura
    McLornan, Donal P.
    Perkins, Andrew
    Yoon, Sung-Soo
    Gupta, Vikas
    Kiladjian, Jean-Jacques
    Donahue, Rafe
    Kawashima, Jun
    Mesa, Ruben A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345